118 related articles for article (PubMed ID: 3165439)
1. Pharmacokinetics of lisuride after subcutaneous infusion.
Krause W; Nieuweboer B; Ruggieri S; Stocchi F; Suchy I
J Neural Transm Suppl; 1988; 27():71-4. PubMed ID: 3165439
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration.
Stocchi F; Ruggieri S; Antonini A; Baronti F; Brughitta G; Bellantuono P; Bravi D; Agnoli A
J Neural Transm Suppl; 1988; 27():27-33. PubMed ID: 3165437
[TBL] [Abstract][Full Text] [Related]
3. Lisuride infusion pump: a device for the treatment of motor fluctuations in Parkinson's disease.
Obeso JA; Luquin MR; Martínez-Lage JM
Lancet; 1986 Mar; 1(8479):467-70. PubMed ID: 2869209
[TBL] [Abstract][Full Text] [Related]
4. One year treatment with lisuride delivery pump in Parkinson's disease.
Ruggieri S; Stocchi F; Carta A; Bragoni M; Agostini C; Barbato L; Agnoli A
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):173-83. PubMed ID: 2748858
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics and pharmacodynamics of lisuride in healthy volunteers after intravenous, intramuscular, and subcutaneous injection.
Krause W; Mager T; Kühne G; Duka T; Voet B
Eur J Clin Pharmacol; 1991; 40(4):399-403. PubMed ID: 2050175
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease.
Vaamonde J; Luquin MR; Obeso JA
Mov Disord; 1990; 5(3):260-2. PubMed ID: 2388647
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Parkinson's disease with subcutaneous lisuride infusions.
Fernandez Pardal M; Micheli F; Gatto M; Perez y Gonzalez N
J Neural Transm Suppl; 1988; 27():75-84. PubMed ID: 2969954
[TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous lisuride infusions in Parkinson's disease.
Critchley PH; Grandas Perez F; Quinn NP; Parkes JD; Marsden CD
J Neural Transm Suppl; 1988; 27():55-60. PubMed ID: 2969953
[TBL] [Abstract][Full Text] [Related]
9. Lisuride infusion pump for Parkinson's disease.
Lancet; 1986 May; 1(8490):1150-1. PubMed ID: 2871399
[No Abstract] [Full Text] [Related]
10. A combined regimen of subcutaneous lisuride and oral Madopar HBS in Parkinson's disease.
Chouza C; Caamaño JL; de Medina O; Aljanati R; Scaramelli A; Romero S
J Neural Transm Suppl; 1988; 27():61-70. PubMed ID: 3042913
[TBL] [Abstract][Full Text] [Related]
11. Lisuride infusion pump for Parkinson's disease.
Lancet; 1986 Aug; 2(8502):348-9. PubMed ID: 2874360
[No Abstract] [Full Text] [Related]
12. Subcutaneous infusion of apomorphine and lisuride in the treatment of parkinsonian on-off fluctuations.
Stibe C; Lees A; Stern G
Lancet; 1987 Apr; 1(8537):871. PubMed ID: 2882282
[No Abstract] [Full Text] [Related]
13. Effect of chronic subcutaneous minipump infusion of lisuride upon locomotor activity of rats.
Wachtel H; Rettig KJ; Löschmann PA
J Neural Transm Suppl; 1988; 27():177-83. PubMed ID: 3165433
[TBL] [Abstract][Full Text] [Related]
14. At the receiving end of the lisuride pump.
Todes CJ
Lancet; 1986 Jul; 2(8497):36-7. PubMed ID: 2873331
[No Abstract] [Full Text] [Related]
15. Radioimmunoassay of plasma lisuride in man following intravenous and oral administration of lisuride hydrogen maleate: effect on plasma prolactin level.
Hümpel M; Nieuweboer B; Hasan SH; Wendt H
Eur J Clin Pharmacol; 1981; 20(1):47-51. PubMed ID: 7308272
[TBL] [Abstract][Full Text] [Related]
16. Comparison between L-dopa and lisuride intravenous infusions: a clinical study.
Ruggieri S; Stocchi F; Carta A; Bravi D; Bragoni M; Giorgi L; Agnoli A
Mov Disord; 1988; 3(4):313-9. PubMed ID: 3211176
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a low-dose subcutaneous lisuride infusion in Parkinson's disease.
Hayashi R; Tako K; Makishita H; Koyama J; Yanagisawa N
Intern Med; 1998 May; 37(5):444-8. PubMed ID: 9652898
[TBL] [Abstract][Full Text] [Related]
18. Lisuride infusion pump in Parkinson's disease. A report of two cases.
Gershanik OS; Scipioni O; García S
J Neural Transm Suppl; 1988; 27():85-90. PubMed ID: 2969955
[TBL] [Abstract][Full Text] [Related]
19. [Continuous dopaminergic stimulation in Parkinson disease].
Obeso JA; Luquin MR; Vaamonde J; Grandas F; Pastor MA; Artieda J; Martínez-Lage JM
Neurologia; 1987; 2(5):227-34. PubMed ID: 2908545
[No Abstract] [Full Text] [Related]
20. Chronic s.c. lisuride in Parkinson's disease--motor-performance and avoidance of psychiatric side effects.
Bittkau S; Przuntek H
J Neural Transm Suppl; 1988; 27():35-54. PubMed ID: 3165438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
